Response to Y. Sasaki et al.: Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer?

類似資料

• Phase II study of FOLFIRINOX for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer
  著者:: Okusaka, Takuji, 等
  出版事項: (2014)
• A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer
  著者:: Suzuki, Eiichiro, 等
  出版事項: (2013)
• Efficacy and safety of axitinib in combination with gemcitabine in advanced pancreatic cancer: subgroup analyses by region, including Japan, from the global randomized Phase III trial
  著者:: Ioka, Tatsuya, 等
  出版事項: (2015)
• Japanese phase I study of GC33, a humanized antibody against glypican-3 for advanced hepatocellular carcinoma
  著者:: Ikeda, Masafumi, 等
  出版事項: (2014)
• Efficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabine
  著者:: Ikeda, Masafumi, 等
  出版事項: (2017)